Charles River Laboratories International: UBS raises target price to $357 from $175
CRL•UBS raised its target price for Charles River Laboratories International to $357 from $175.
Related News
Cytomed Therapeutics six-month loss narrows to S$1.79 million; revenue rises to S$157,289
GDTC•
Vida Global partners with AVANT to expand AI agent platform distribution through trusted advisor network
VIDA•
Silo Pharma unit QwikAgents adds NVIDIA Nemotron model support
SILO•
Traders see fading chance of October Fed rate hike
TLT•
Wells Fargo cuts GE Aerospace target price to $380 from $390
GE•